BCL2L1 and non-Hodgkin lymphoma: The BCL-XL-selective inhibitor A-1155463 showed no single agent activity and did not synergize with A-1210477 in BCL2High NHL cells in vitro, further emphasizing the importance of BCL-2 inhibition in the BCL2High subtype.